A detailed history of Drake & Associates, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Drake & Associates, LLC holds 708 shares of VRTX stock, worth $281,267. This represents 0.11% of its overall portfolio holdings.

Number of Shares
708
Previous 467 51.61%
Holding current value
$281,267
Previous $218,000 50.92%
% of portfolio
0.11%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$460.0 - $505.78 $110,860 - $121,892
241 Added 51.61%
708 $329,000
Q2 2024

Aug 05, 2024

SELL
$392.81 - $485.53 $22,390 - $27,675
-57 Reduced 10.88%
467 $218,000
Q1 2024

May 09, 2024

BUY
$407.69 - $446.08 $213,629 - $233,745
524 New
524 $219,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Drake & Associates, LLC Portfolio

Follow Drake & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drake & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drake & Associates, LLC with notifications on news.